Progyny(PGNY) Newsfilter·2024-05-22 21:00Core Viewpoint - Progyny, Inc. has announced a new share repurchase program to buy back up to $100 million of its common stock, following a previous program announced on February 29, 2024, which will be funded through available cash balances [1]. Company Overview - Progyny is a transformative solution for fertility, family building, and women's health benefits, trusted by leading employers, health plans, and benefit purchasers [3]. - The company aims to create a world where everyone can achieve their family and health aspirations, demonstrating that comprehensive and inclusive solutions benefit employers, patients, and physicians [3]. Benefits and Services - Progyny's benefits solution includes concierge support, coaching, education, and digital tools, providing access to a premier network of fertility and women's health specialists who utilize the latest science and technologies [4]. - The company focuses on driving optimal clinical outcomes while reducing healthcare costs [4]. Recognition and Awards - Progyny has received multiple accolades for its leadership and growth, including recognition from CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC [5].